Anacor Pharmaceuticals, Inc.
(NASDAQ : ANAC)

( )
ANAC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.06%140.460.6%$751.99m
PFEPfizer Inc.
-0.55%43.270.9%$746.25m
MRKMerck & Co., Inc.
-0.61%69.990.6%$454.63m
ABBVAbbVie, Inc.
-1.72%91.022.1%$355.45m
LLYEli Lilly and Company
-1.04%105.771.0%$323.34m
BMYBristol-Myers Squibb Company
-1.12%60.791.4%$265.31m
AZNAstraZeneca PLC Sponsored ADR
-0.53%37.291.3%$130.39m
NVSNovartis AG Sponsored ADR
-0.15%84.900.2%$112.85m
GSKGlaxoSmithKline plc Sponsored ADR
-0.23%39.540.2%$75.20m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.91%47.000.1%$52.52m
SNYSanofi Sponsored ADR
-0.14%43.900.2%$44.18m
LCILannett Company, Inc.
2.63%4.8837.0%$15.26m
AKTXAkari Therapeutics Plc Sponsored ADR
3.34%2.081.7%$0.13m
EPIXESSA Pharma Inc
2.61%3.150.1%$0.04m

Company Profile

Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA.